Early treatment with lorlatinib improves survival in some lung cancer patients

Lung cancer patients with a specific genetic alteration lived longer and were protected against metastasis to the brain when treated early with the drug lorlatinib (Lorbrena), according to a study led by researchers at Massachusetts General Hospital (MGH), published in the New England Journal of Medicine (NEJM). Non-small-cell lung cancer (NSCLC) accounts for 87% of […]

Continue Reading

Beijing seeks talks on joint inspection of U.S.-listed Chinese firms

China’s securities regulator said on Friday it looked forward to holding discussions with its U.S. counterparts as soon as possible on “specific plans” to conduct joint inspections of Chinese firms listed in the United States. Washington has long complained of lack of access to audit working papers for U.S.-listed Chinese companies and in August threatened […]

Continue Reading